title: Drug therapy of neurovascular disease.
abstract: The goal of therapy for acute stroke is immediate treatment to reduce the risk of permanent neurologic disability and death. For ischemic stroke, it is imperative to reestablish brain perfusion while at the same time trying to preserve neuronal function. Early treatment of hemorrhagic stroke, particularly subarachnoid hemorrhage, also may improve clinical outcome. Prevention of stroke still remains the most important treatment strategy. In this review, pharmacologic strategies to both prevent and treat thrombotic, embolic, and hemorrhagic strokes are discussed. Treatment modalities for other cerebrovascular disease entities, migraine syndrome, and vascular dementia also are reviewed.
authors.affiliation: Division of Neurology, Mt. Sinai Medical Center, New York, New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: Weinberger
authors.forename: D
authors.initials: D
authors.lastname: Terashita
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply; D001929:Brain Edema / Q000628:therapy; D002543:Cerebral Hemorrhage / Q000628:therapy; D015140:Dementia, Vascular / Q000628:therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012640:Seizures / Q000628:therapy; D020521:Stroke / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D018696:Neuroprotective Agents; D010975:Platelet Aggregation Inhibitors